Non-invasive evaluation of liver fibrosis using transient elastography

Journal of Hepatology

Volumn 48, Issue 5, 2008, Pages 835-847

  Castera, Laurent ^a   Forns, Xavier ^b   Alberti, Alfredo ^c  

^a HÔPITAL SAINT ANDRÉ   (France)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

FibroScan; Liver fibrosis; Reproducibility; Transient elastography

Indexed keywords

ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; ELASTOGRAPHY; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; OBESITY; PORTAL HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RIGIDITY;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; HEPATITIS C; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; RECURRENCE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 41249100719     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.02.008     Document Type: Article

References (70)

1. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol 1999;31(Suppl. 1):3-8.
2. NIH Consensus Statement on Management of Hepatitis C: 2002. Hepatology 2002;36:S3-S20.
3. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
4. Cadranel J.F., Rufat P., and Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the group of epidemiology of the french association for the study of the liver (AFEF). Hepatology 32 (2000) 477-481
5. Castera L., Negre I., Samii K., and Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 30 (1999) 1529-1530
6. Bedossa P., Dargère D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
7. Rousselet M.C., Michalak S., Dupre F., Croue A., Bedossa P., Saint-Andre J.P., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41 (2005) 257-264
8. Afdhal N.H. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests?. Hepatology 37 (2003) 972-974
9. Afdhal N.H., and Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99 (2004) 1160-1174
10. Rockey D.C., and Bissell D.M. Non-invasive measures of liver fibrosis. Hepatology 43 (2006) S113-S120
11. Castera L., and Pawlotsky J.M. Non-invasive diagnosis of liver fibrosis in patients with chronic hepatitis C. MedGenMed 7 (2005) 39
12. Sebastiani G., and Alberti A. Non-invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 12 (2006) 3682-3694
13. Sandrin L., Fourquet B., Hasquenoph J.M., Yon S., Fournier C., Mal F., et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003) 1705-1713
14. Fraquelli M., Rigamonti C., Casazza G., Conte D., Donato M.F., Ronchi G., et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56 (2007) 968-973
15. Kettaneh A., Marcellin P., Douvin C., Poupon R., Ziol M., Beaugrand M., et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 46 (2007) 628-634
16. Lucidarme D., Foucher J., Le Bail B., Castera L., Villars S., Forzy G., et al. The ratio interquartile range/median value of liver stiffness measurements is a key factor of accuracy of transient elastography (FibroScan) for the diagnosis of liver fibrosis (abstract). Hepatology 46 (2007) 318A
17. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
18. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., et al. Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54
19. Foucher J., Chanteloup E., Vergniol J., Castera L., Le Bail B., Adhoute X., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55 (2006) 403-408
20. Ganne-Carrie N., Ziol M., de Ledinghen V., Douvin C., Marcellin P., Castera L., et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 44 (2006) 1511-1517
21. Coco B., Oliveri F., Maina A.M., Ciccorossi P., Sacco R., Colombatto P., et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14 (2007) 360-369
22. Foucher J., Castera L., Bernard P.H., Adhoute X., Laharie D., Bertet J., et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 18 (2006) 411-412
23. Arena U., Vizzutti F., Corti G., Ambu S., Stasi C., Bresci S., et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47 (2008) 380-384
24. Sagir A., Erhardt A., Schmitt M., and Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 47 (2007) 592-595
25. Konate A., Reaud S., Quenemer E., Fouchard-Hubert I., Oberti F., and Cales P. Liver stiffness measurement by transient elastography: predictive factors of accuracy and reproducibility (abstract). J Hepatol 44 (2006) S195
26. Roulot D., Czernichow S., Le Clésiau H., Costes J.-L., Vergnaud A.-C., and Beaugrand M. Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome. J Hepatol 48 (2008) 606-613
27. Corpechot C., El Naggar A., and Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex?. Hepatology 44 (2006) 513-514
28. Kim K.M., Choi W.B., Park S.H., Yu E., Lee S.G., Lim Y.S., et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol 42 (2007) 382-388
29. Afdhal N.H., and Curry M. Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis. J Hepatol 46 (2007) 543-545
30. Gomez-Dominguez E., Mendoza J., Rubio S., Moreno-Monteagudo J.A., Garcia-Buey L., and Moreno-Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 24 (2006) 513-518
31. Marcellin P., de Ledinghen V., Dhumeaux D., Poupon R., Ziol M., Bedossa P., et al. Non-invasive assessment of liver fibrosis in chronic hepatitis B using FibroScan (abstract). Hepatology 42 (2005) 715A
32. de Ledinghen V., Douvin C., Kettaneh A., Ziol M., Roulot D., Marcellin P., et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 41 (2006) 175-179
33. Vergara S., Macias J., Rivero A., Gutierrez-Valencia A., Gonzalez-Serrano M., Merino D., et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 45 (2007) 969-974
34. Corpechot C., El Naggar A., Poujol-Robert A., Ziol M., Wendum D., Chazouilleres O., et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43 (2006) 1118-1124
35. Kelleher T., MacFarlane C., de Ledinghen V., Beaugrand M., Foucher J., Castera L., et al. Risk factors and hepatic elastography (FibroScan) in the prediction of hepatic fibrosis in non-alcoholic steatohepatitis (abstract). Gastroenterology 130 (2006) A736
36. Yoneda M., Fujita K., Inamori M., Nakajima A., Tamano M., and Hiraishi H. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 56 (2007) 1330-1331
37. Talwalkar J.A., Kurtz D.M., Schoenleber S.J., West C.P., and Montori V.M. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 5 (2007) 1214-1220
38. Castera L., Bernard P.H., Le Bail B., Foucher J., Merrouche W., Couzigou P., et al. What is the best non-invasive method for early prediction of cirrhosis in chronic hepatitis C? Prospective comparison between Fibroscan and serum markers (Lok index, APRI, AST/ALT ratio, platelet count and Fibrotest) (abstract). Hepatology 46 (2007) 156A
39. Poynard T., Halfon P., Castera L., Munteanu M., Imbert-Bismut F., Ratziu V., et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 53 (2007) 1615-1622
40. Poynard T., Ingiliz P., Munteanu M., Lebray P., Morra R., Messous D., et al. Concordance between FibroTest (FT) and FibroScan (FS): a new non-invasive methodology to improving accuracy in a world without a gold standard (abstract). Hepatology 44 (2007) 189A
41. Castera L., Le Bail B., Foucher J., Bertet J., Darriet M., Couzigou P., et al. Prospective analysis of discordance between FibroScan and FibroTest when used in combination as first-line assessment of liver fibrosis in chronic hepatitis C (Abstract). Hepatology 42 (2005) 440A
42. Non-invasive methods for the evaluation of hepatic fibrosis/cirrhosis. www.has-sante.fr, 2006.
43. Martinez S.M., Domi{dotless}́nguez M., Fernandez-Varo G., Gonzalez P., Bataller R., Sampson E., et al. Performance of non-invasive methods in the assessment of disease severity in routine clinical practice in patients with chronic hepatitis C (abstract). Hepatology 46 (2007) 318A
44. Sebastiani G., Vario A., Guido M., Noventa F., Plebani M., Pistis R., et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 4 (2006) 686-693
45. Castera L., Sebastiani G., Le Bail B., de Ledinghen V., Couzigou P., and Alberti A. Prospective comparison of two algorithms combining non-invasive tests for staging of fibrosis in chronic hepatitis C (abstract). Hepatology 46 (2007) 320A
46. Castera L., Foucher J., Bertet J., Couzigou P., and de Ledinghen V. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology 43 (2006) 373-374
47. Colletta C., Smirne C., Fabris C., Toniutto P., Rapetti R., Minisini R., et al. Value of two non-invasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 42 (2005) 838-845
48. Moreno-Otero R., Trapero-Marugan M., and Mendoza J. Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase. Gut 55 (2006) 1055-1056
49. Castera L., Foucher J., Bernard P.H., Bertet J., Couzigou P., and de Lédinghen V. Transient elastography (FibroScan) and FibroTest to assess liver fibrosis in inactive hepatitis B carriers: a prospective controlled study (abstract). Hepatology 44 (2006) 489A
50. Pinzani M. Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched. Gut 55 (2006) 310-312
51. Kazemi F., Kettaneh A., N'Kontchou G., Pinto E., Ganne-Carrie N., Trinchet J.C., et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 45 (2006) 230-235
52. Vizzutti F., Arena U., Romanelli R.G., Rega L., Foschi M., Colagrande S., et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 45 (2007) 1290-1297
53. Carrion J.A., Navasa M., Bosch J., Bruguera M., Gilabert R., and Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 12 (2006) 1791-1798
54. Bureau C., Metivier S., Peron J.M., Robic M.A., Rouquet O., Dupuis E., et al. Prospective assessment of liver stiffness for the non-invasive prediction of portal hypertension (abstract). J Hepatol 46 (2007) S34
55. Lemoine M., Katsahian S., Nahon P., Ganne-Carrie N., Kazemi F., Grando V., et al. Liver stiffness measurement is correlated with hepatic venous pressure gradient in patients with uncomplicated alcoholic and/or HCV related cirrhosis (abstract). Hepatology 44 (2006) 204A
56. Garcia-Samaniego J., and Forns X. Hepatitis C virus and human immunodeficiency virus: the un-won battle. Hepatology 46 (2007) 611-614
57. Lim J.K., and Groszmann R.J. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?. Hepatology 45 (2007) 1087-1090
58. Bosch J. Predictions from a hard liver. J Hepatol 45 (2006) 174-177
59. Bureau C., Robic M.A., Metivier S., Peron J.M., Rouquet O., Dupuis E., et al. Prognostic value of liver stiffness measurement and hepatic venous pressure gradient in patients with chronic liver disease: a prospective study (abstract). Hepatology 46 (2007) 572A
60. Rigamonti C., Donato M.F., Fraquelli M., Agnelli F., Ronchi G., Casazza G., et al. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis c after liver transplantation. Gut (2008) 10.1136/gut.2007.135046
61. Castera L., Denis J., Babany G., and Roudot-Thoraval F. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?. J Hepatol 46 (2007) 528-529
62. deLedinghen V., Castera L., Foucher J., Tournan R., Bernard P.H., Moisset G., et al. Evaluation of fibrosis evolution using non-invasive methods according to sustained virological response in HCV patients: a pilot prospective controlled study (abstract). Hepatology 44 (2006) 337A
63. Hézode C., Castéra L., Rosa I., Roulot D., Leroy V., Bouvier-Alias M., et al. Dynamics of liver stiffness during peginterferon alpha-ribavirin treatment in patients with chronic hepatitis C (abstract). Hepatology 46 (2007) 366A
64. Takeda T., Yasuda T., Nakayama Y., Nakaya M., Kimura M., Yamashita M., et al. Usefulness of non-invasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol 12 (2006) 7768-7773
65. de Ledinghen V., Le Bail B., Rebouissoux L., Fournier C., Foucher J., Miette V., et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 45 (2007) 443-450
66. Huwart L., Sempoux C., Salameh N., Jamart J., Annet L., Sinkus R., et al. Liver fibrosis: non-invasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245 (2007) 458-466
67. Yin M., Talwalkar J.A., Glaser K.J., Manduca A., Grimm R.C., Rossman P.J., et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5 (2007) 1207-1213
68. Friedrich-Rust M., Ong M.F., Herrmann E., Dries V., Samaras P., Zeuzem S., et al. Real-time elastography for non-invasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 188 (2007) 758-764
69. Lewin M., Poujol-Robert A., Boelle P.Y., Wendum D., Lasnier E., Viallon M., et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46 (2007) 658-665
70. Huwart L., Sempoux C., Salameh N., Annet L., Horsmans Y., and Van Beers B.E. Comparison of MR elastography, ultrasound elastography and APRI for the non-invasive assessment of liver fibrosis (abstract). Hepatology 46 (2007) 319A